|
Total
|
1997
|
1998
|
1999
|
2000
|
2001
|
2002
|
2003
|
2004
|
2005
|
2006
|
2007
|
p-value‡
|
---|
|
N = 44,491
|
N = 4,479
|
N = 4,412
|
N = 4,857
|
N = 5,262
|
N = 4,258
|
N = 4,063
|
N = 3,688
|
N = 3,773
|
N = 3,486
|
N = 3,354
|
N = 2,859
| |
Age (years)
| | | | | | | | | | | | | | | | | | | | | | | | | |
18-< 50
|
35,093
|
79%
|
3,698
|
83%
|
3,624
|
82%
|
3,953
|
81%
|
4,244
|
81%
|
3,344
|
79%
|
3,158
|
78%
|
2,855
|
77%
|
2,912
|
77%
|
2,709
|
78%
|
2,516
|
75%
|
2,080
|
73%
|
< 0.01
|
≥50
|
9,398
|
21%
|
781
|
17%
|
788
|
18%
|
904
|
19%
|
1,018
|
19%
|
914
|
21%
|
905
|
22%
|
833
|
23%
|
861
|
23%
|
777
|
22%
|
838
|
25%
|
779
|
27%
|
< 0.01
|
AIDS-defining illness
| | | | | | | | | | | | | | | | | | | | | | | |
18-< 50
|
3,390
|
10%
|
417
|
11%
|
385
|
11%
|
362
|
9%
|
370
|
9%
|
344
|
10%
|
331
|
10%
|
277
|
10%
|
270
|
9%
|
251
|
9%
|
208
|
8%
|
175
|
8%
|
< 0.01
|
≥50
|
1,242
|
13%
|
142
|
18%
|
127
|
16%
|
119
|
13%
|
121
|
12%
|
133
|
15%
|
119
|
13%
|
105
|
13%
|
105
|
12%
|
102
|
13%
|
95
|
11%
|
74
|
9%
|
< 0.01
|
CD4+ T-cell Count (cells/mm
3
)
| | | | | | | | | | | | | | | | | | | | | | | |
18-< 50
| | | | | | | | | | | | | | | | | | | | | | | | | |
Median
|
298
|
269
|
277
|
275
|
284
|
293
|
313
|
296
|
312
|
323
|
333
|
336
|
< 0.01
|
IQR
|
112-493
|
100-467
|
96-481
|
99-464
|
104-494
|
100-494
|
124-501
|
114-504
|
127-499
|
134-500
|
141-512
|
152-522
| |
≥50
| | | | | | | | | | | | | | | | | | | | | | | | | |
Median
|
251
|
203
|
211
|
246
|
261
|
234
|
272
|
274
|
261
|
272
|
273
|
266
|
< 0.01
|
IQR
|
90-457
|
80-390
|
65-403
|
88-440
|
102-464
|
88-443
|
111-457
|
92-475
|
83-487
|
81-511
|
107-491
|
111-494
| |
- ‡P-values calculated using Cochran-Armitage test for categorical variables or Cuzick's test for continuous variables.